Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Also in the Knowledge Center
/ Jan 01, 1999
Process for the preparation of purified crystalline iohexol by crystallization using ethanol
Read more
Scientific Article
Scientific Article
/ Jan 01, 1988
Isolation and x-ray crystal structure analysis of a hydrazine-containing rhodium catalyst, [(MeOH)2H]+[RhCl4(PPh3)(NHMeNHMe)]-
Read more
Scientific Article